recently published overview of the literature on post-mastectomy radiation therapy (PMRT) for inflammatory breast cancer (IBC) cited a range for 5-year locoregional control (LRC) after INNO-206 (Aldoxorubicin) PMRT from 73% to 92% (1). make sure LRC in this difficult circumstance. The radiation treatment dose and techniques described across series reporting IBC outcomes vary. The University… Continue reading recently published overview of the literature on post-mastectomy radiation therapy (PMRT)